What an MDT discussion is meant to settle
A multidisciplinary team discussion brings together clinicians from different specialties to review one case together. For colorectal cancer, that can involve surgery, medical oncology, radiation oncology, radiology and pathology. The purpose is not to produce a general opinion about cancer. It is to produce a coordinated position on the specific decisions this patient faces now.
That distinction matters when you are considering care in China as an overseas patient. You are not asking whether a group of doctors exists. You are asking whether a structured discussion will answer the questions that determine your next step. If the discussion does not address those questions, the meeting may still happen without resolving your decision.
The National Cancer Institute explains that cancer stage describes the extent of disease, and that staging approaches differ between cancer types. That is a useful starting point: a colorectal MDT needs to work from the staging information relevant to colorectal cancer, not from a generic summary.
Question one: are the pathology and staging complete enough to decide anything?
The first question is whether the team has enough information to make a recommendation. For colorectal cancer, that usually means a pathology report that confirms the type of cancer and a staging assessment that describes how far it has spread. If either is incomplete, the discussion may end with a request for more information rather than a treatment plan.
Ask specifically: what is the confirmed diagnosis, what staging information is available, and what is missing? If a biopsy was done elsewhere, ask whether the slides or blocks need to be reviewed locally. If imaging was done elsewhere, ask whether it is acceptable or whether repeat imaging is needed. These are practical questions, not challenges to the team.
The NCI source notes that staging approaches differ between cancer types. This means you should not assume that a staging label from one context transfers automatically to another. Ask the team to explain what staging system they are using and what it tells them about your situation.
A useful follow-up: if the pathology or staging is incomplete, what specific information would change the recommendation? This tells you whether the missing piece is minor or central.
Question two: what do previous operations mean for the options now?
Previous surgery changes the picture. If you have already had part of your colon or rectum removed, the team needs to know what was done, when, and what the margins and lymph nodes showed. If you have had a stoma formed, that affects both surgical planning and the sequence of treatment.
Ask the team to explain how your previous operations affect what is possible now. For example: does the previous surgery limit the options for further surgery? Does it change how radiation can be used? Does it affect the timing of chemotherapy? These are questions for the treating clinicians, not something you need to resolve yourself.
Bring a clear surgical history: dates, hospital names, procedure names and any discharge summaries. If you do not have the operative reports, ask the hospital whether they can be obtained. The team cannot account for an operation it cannot see.
One practical point: if you have had surgery elsewhere, ask whether the team wants to review the original pathology slides. This is a common request and helps confirm the diagnosis before planning further treatment.
Question three: which treatment comes first, and why?
For colorectal cancer, the order of treatment matters. Sometimes surgery comes first. Sometimes chemotherapy or radiation comes before surgery. Sometimes the plan is to start with systemic treatment and reassess. The MDT discussion should produce a clear answer about the recommended sequence and the reasoning behind it.
Ask: what is the recommended first step, and what is the goal of that step? Is it to shrink the tumour before surgery, to control symptoms, or to treat disease that has spread? What is the plan if the first step does not achieve its goal? These questions help you understand the logic, not just the instruction.
Also ask what alternatives were considered. If the team discussed more than one option, what made them choose this one? This is not about second-guessing the recommendation. It is about understanding whether the decision is clear-cut or whether there is genuine uncertainty.
If the recommendation involves a treatment that is not available where you live, ask how that affects the plan. The team should be able to explain whether the recommendation depends on a specific approach or whether alternatives exist.
Question four: what is still uncertain, and what would change the plan?
A good MDT discussion should be honest about uncertainty. Ask the team: what are you still unsure about? What information would change your recommendation? This is not a sign of weakness. It tells you where the real decision points are.
For example, the team may be uncertain whether a tumour is resectable, whether a particular genetic test result would open a different treatment option, or whether the patient is fit enough for a specific approach. Knowing this helps you prepare for the next step, whether that is more tests, a repeat discussion, or a decision to proceed.
Ask how the plan will be reviewed. If you start treatment, when will the team reassess? What would prompt a change in direction? This gives you a sense of how the plan will adapt over time.
Finally, ask what you should do if your situation changes before treatment starts. If you develop new symptoms, who should you contact? This is a practical safety question, not a clinical one.
What to prepare before asking for an MDT discussion in China
If you are considering care in China, you will need to ask the hospital directly whether it offers a multidisciplinary discussion for colorectal cancer and how to request one. Do not assume that every hospital provides this format or that it is automatic. The hospital decides whether a case is suitable for review and how that review is organised.
Prepare a concise summary: your diagnosis, the date of diagnosis, any surgery you have had, the treatments you have received, and your main question. Include copies of pathology reports, imaging reports and operative notes if you have them. If you do not have them, say so clearly so the team can tell you what they need.
Ask the hospital what it needs from you and in what format. Ask whether reports need to be translated, whether original slides are required, and whether the review can be done remotely or requires travel. These are administrative questions, and the answers vary by hospital.
You can start with a brief enquiry to ChinaSpecialistCare. Our team checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. This is not a diagnosis or a promise of acceptance. An initial enquiry is free and does not require buying a proxy consultation.
If you want to understand how a staging review is structured before you approach a hospital, the cancer staging review page explains the general process. Use it to prepare your questions, not as a substitute for the hospital's own assessment.
- Confirmed diagnosis and date
- Pathology report and staging information available
- Previous operations with dates and reports if available
- Treatments already received
- Your main question for the team
- Any records you do not have
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.